Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


25.03.2019

1 Anticancer Res
2 Biochem Biophys Res Commun
1 BMC Cancer
1 BMC Gastroenterol
1 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
4 Eur Radiol
2 Gastroenterology
2 Gut
8 Hepatology
1 J Gastroenterol Hepatol
1 J Hepatol
3 J Pediatr
2 J Pediatr Surg
1 Lancet
1 Oncogene
6 PLoS One
2 Proc Natl Acad Sci U S A
11 Transplant Proc
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. UMEZAKI N, Hashimoto D, Yamashita YI, Nakagawa S, et al
    Neuroendocrine Tumor of the Hilar Bile Duct.
    Anticancer Res. 2019;39:903-907.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. ZHAO A, Jiang F, Yang G, Liu H, et al
    Sfrp5 interacts with Slurp1 to regulate the accumulation of triglycerides in hepatocyte steatosis model.
    Biochem Biophys Res Commun. 2019 Mar 15. pii: S0006-291X(19)30412.
    PubMed     Text format     Abstract available

  3. JI D, Wang Y, Li H, Sun B, et al
    Long non-coding RNA LINC00461/miR-149-5p/LRIG2 axis regulates hepatocellular carcinoma progression.
    Biochem Biophys Res Commun. 2019 Mar 14. pii: S0006-291X(19)30426.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. LAI MW, Chu YD, Lin CL, Chien RN, et al
    Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
    BMC Cancer. 2019;19:250.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. SHI Y, Huang B, Deng R, Ma Y, et al
    The Association of obesity with vascular complications after liver transplantation.
    BMC Gastroenterol. 2019;19:39.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  6. LANKARANI KB
    Challenging issues in the management of Wilson's disease.
    Clin Res Hepatol Gastroenterol. 2018;42:e95-e96.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. SAFFO S, Taddei TH
    Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.
    Dig Dis Sci. 2019 Mar 18. pii: 10.1007/s10620-019-05582.
    PubMed     Text format     Abstract available

  8. YOON YI, Lee SG
    Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective.
    Dig Dis Sci. 2019 Mar 20. pii: 10.1007/s10620-019-05551.
    PubMed     Text format     Abstract available


    Eur Radiol

  9. GU J, Liu S, Du S, Zhang Q, et al
    Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
    Eur Radiol. 2019 Mar 21. pii: 10.1007/s00330-019-06072.
    PubMed     Text format     Abstract available

  10. FALLER TL, Trotier AJ, Miraux S, Ribot EJ, et al
    Radial MP2RAGE sequence for rapid 3D T1 mapping of mouse abdomen: application to hepatic metastases.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06081.
    PubMed     Text format     Abstract available

  11. BIKO DM, Smith CL, Otero HJ, Saul D, et al
    Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06112.
    PubMed     Text format     Abstract available

  12. YIN Z, Murphy MC, Li J, Glaser KJ, et al
    Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06076.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. LOMBARDI A, Mondelli MU, Bruno R
    RE: Effects of long-term norfloxacin therapy in patients with advanced cirrhosis.
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33560.
    PubMed     Text format    

  14. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.
    PubMed     Text format    


    Gut

  15. DE TONI EN, Schlesinger-Raab A, Fuchs M, Schepp W, et al
    Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
    Gut. 2019 Mar 16. pii: gutjnl-2018-318193. doi: 10.1136/gutjnl-2018-318193.
    PubMed     Text format     Abstract available

  16. CUBERO FJ, Martinez-Chantar ML
    Plasticity of adult hepatocytes and readjustment of cell fate: a novel dogma in liver disease.
    Gut. 2019 Mar 18. pii: gutjnl-2019-318218. doi: 10.1136/gutjnl-2019-318218.
    PubMed     Text format    


    Hepatology

  17. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    PubMed     Text format     Abstract available

  18. XU X, Krumm C, So JS, Bare CJ, et al
    Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction.
    Hepatology. 2018;68:2167-2181.
    PubMed     Text format     Abstract available

  19. SU GL, Glass L, Tapper EB, Van T, et al
    Virtual Consultations Through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans With Liver Disease.
    Hepatology. 2018;68:2317-2324.
    PubMed     Text format     Abstract available

  20. GE X, Arriazu E, Magdaleno F, Antoine DJ, et al
    High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Hepatology. 2018;68:2380-2404.
    PubMed     Text format     Abstract available

  21. ALLEN AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, et al
    Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database.
    Hepatology. 2018;68:2230-2238.
    PubMed     Text format     Abstract available

  22. CALVOPINA DA, Chatfield MD, Weis A, Coleman MA, et al
    MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Hepatology. 2018;68:2301-2316.
    PubMed     Text format     Abstract available

  23. MIN JH, Kim JM, Kim YK, Kang TW, et al
    Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System.
    Hepatology. 2018;68:2254-2266.
    PubMed     Text format     Abstract available

  24. LOPICCOLO J, Brener MI, Oshima K, Lipson EJ, et al
    Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade.
    Hepatology. 2018;68:2431-2433.
    PubMed     Text format    


    J Gastroenterol Hepatol

  25. CHEN CJ, Wang LC, Kuo HT, Fang YC, et al
    Late-evening snacking improves liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14665.
    PubMed     Text format     Abstract available


    J Hepatol

  26. BAYO J, Fiore EJ, Dominguez LM, Real A, et al
    A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
    J Hepatol. 2019 Mar 14. pii: S0168-8278(19)30148.
    PubMed     Text format     Abstract available


    J Pediatr

  27. SHORES DR, Alaish SM, Aucott SW, Bullard JE, et al
    Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure-Associated Liver Disease in Surgical Infants.
    J Pediatr. 2018 Feb 2. pii: S0022-3476(17)31614.
    PubMed     Text format     Abstract available

  28. CHAUSSY Y, Manzoni P, Ridley A, Auber F, et al
    An Unusual Cause of Abdominal Pain.
    J Pediatr. 2018 Jan 12. pii: S0022-3476(17)31656.
    PubMed     Text format    

  29. KIM DR, Lee MS, Lee JS, Choi GM, et al
    Ultrasonographic Quantitative Analysis of Fatty Pancreas in Obese Children: Its Correlation with Metabolic Syndrome and Homeostasis Model Assessment of Insulin Resistance.
    J Pediatr. 2018;193:134-138.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  30. RAMOS-GONZALEZ G, Elisofon S, Dee EC, Staffa SJ, et al
    Predictors of Need for Liver Transplantation in Children Undergoing Hepatoportoenterostomy for Biliary Atresia.
    J Pediatr Surg. 2019 Mar 1. pii: S0022-3468(19)30192.
    PubMed     Text format     Abstract available

  31. STAFMAN LL, Waldrop MG, Williams AP, Aye JM, et al
    The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
    J Pediatr Surg. 2019 Feb 28. pii: S0022-3468(19)30170.
    PubMed     Text format     Abstract available


    Lancet

  32. SARGENT J, Horton R
    Transforming the landscape of liver disease in the UK.
    Lancet. 2018;392:2332-2333.
    PubMed     Text format    


    Oncogene

  33. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    PubMed     Text format     Abstract available


    PLoS One

  34. FERRARA-ROMEO I, Martinez P, Blasco MA
    Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.
    PLoS One. 2018;13:e0204909.
    PubMed     Text format     Abstract available

  35. ALMEER RS, El-Khadragy MF, Abdelhabib S, Abdel Moneim AE, et al
    Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
    PLoS One. 2018;13:e0204923.
    PubMed     Text format     Abstract available

  36. IOANNOU GN, Green P, Lowy E, Mun EJ, et al
    Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.
    PLoS One. 2018;13:e0204412.
    PubMed     Text format     Abstract available

  37. TSAI YW, Tzeng IS, Chen YC, Hsieh TH, et al
    Survival prediction among patients with non-cancer-related end-stage liver disease.
    PLoS One. 2018;13:e0202692.
    PubMed     Text format     Abstract available

  38. OKABE H, Yoshizumi T, Yamashita YI, Imai K, et al
    Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0203856.
    PubMed     Text format     Abstract available

  39. POLINENI D, Piccorelli AV, Hannah WB, Dalrymple SN, et al
    Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    PLoS One. 2018;13:e0205257.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. FENG Z, Zou X, Chen Y, Wang H, et al
    Modulation of HIF-2alpha PAS-B domain contributes to physiological responses.
    Proc Natl Acad Sci U S A. 2018;115:13240-13245.
    PubMed     Text format     Abstract available

  41. CORDERO-HERRERA I, Kozyra M, Zhuge Z, McCann Haworth S, et al
    AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis.
    Proc Natl Acad Sci U S A. 2019;116:217-226.
    PubMed     Text format     Abstract available


    Transplant Proc

  42. FOUZAS I, Papanikolaou C, Katsanos G, Antoniadis N, et al
    Hepatic Artery Anatomic Variations and Reconstruction in Liver Grafts Procured in Greece: The Effect on Hepatic Artery Thrombosis.
    Transplant Proc. 2019;51:416-420.
    PubMed     Text format     Abstract available

  43. MARTINEZ-INSFRAN LA, Ramirez P, Cascales P, Alconchel F, et al
    Early Outcomes of Liver Transplantation Using Donors After Circulatory Death in Patients With Hepatocellular Carcinoma: A Comparative Study.
    Transplant Proc. 2019;51:359-364.
    PubMed     Text format     Abstract available

  44. SOTIROPOULOS GC, Machairas N, Fouzas I, Vernadakis S, et al
    Prediction of Microvascular Tumor Invasion in Liver Transplant Candidates With Hepatocellular Carcinoma: A Feasible Concept or a Misleading Illusion?
    Transplant Proc. 2019;51:421-423.
    PubMed     Text format     Abstract available

  45. AYLLON MD, Ciria R, Gomez-Luque I, Rodriguez-Peralvarez M, et al
    Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
    Transplant Proc. 2019;51:41-43.
    PubMed     Text format     Abstract available

  46. GARCIA-SESMA A, Calvo J, Manrique A, Cambra F, et al
    Morbidly Obese Patients Awaiting Liver Transplantation-Sleeve Gastrectomy: Safety and Efficacy From a Liver Transplant Unit Experience.
    Transplant Proc. 2018 Jun 28. pii: S0041-1345(18)30834.
    PubMed     Text format     Abstract available

  47. BUSH WJ, Davis JP, Maluccio MA, Kubal CA, et al
    Computed Tomography Measures of Nutrition in Patients With End-Stage Liver Disease Provide a Novel Approach to Characterize Deficits.
    Transplant Proc. 2018;50:3501-3507.
    PubMed     Text format     Abstract available

  48. KIMURA K, Kudo K, Kurihara T, Yoshiya S, et al
    Rendezvous Technique Using Double Balloon Endoscope for Removal of Multiple Intrahepatic Bile Duct Stones in Hepaticojejunostomy After Living Donor Liver Transplant: A Case Report.
    Transplant Proc. 2019;51:579-584.
    PubMed     Text format     Abstract available

  49. CHOLONGITAS E, Antoniadis N, Goulis I, Theocharidou E, et al
    Trough Levels of Everolimus Are Associated With Recurrence Rates of Hepatocellular Carcinoma After Liver Transplantation.
    Transplant Proc. 2019;51:450-453.
    PubMed     Text format     Abstract available

  50. PRODROMIDOU A, Machairas N, Garoufalia Z, Kostakis ID, et al
    Liver Transplantation for Giant Hepatic Hemangioma: A Systematic Review.
    Transplant Proc. 2019;51:440-442.
    PubMed     Text format     Abstract available

  51. MACHAIRAS N, Stamopoulos P, Kostakis ID, Garoufalia Z, et al
    Mixed Hepatocellular Cholangiocarcinoma: A Review of Long-Term Outcomes Following Liver Transplantation.
    Transplant Proc. 2019;51:437-439.
    PubMed     Text format     Abstract available

  52. KOSTAKIS ID, Machairas N, Prodromidou A, Stamopoulos P, et al
    Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Transplant Proc. 2019;51:433-436.
    PubMed     Text format     Abstract available


    Transplantation

  53. GUSTAFSON E, Hamad OA, Deckmyn H, Barbu A, et al
    Exposure of von Willebrand factor on isolated hepatocytes promotes tethering of platelets to the cell surface.
    Transplantation. 2019 Mar 21. doi: 10.1097/TP.0000000000002707.
    PubMed     Text format     Abstract available

  54. SHIRABE K, Eguchi S, Okajima H, Hasegawa K, et al
    Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.
    Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126.
    PubMed     Text format     Abstract available

  55. MOON JI, Schiano TD, Burnham A, Lam K, et al
    Small-for-size Syndrome Does Not Occur in Intestinal Transplantation Without Liver Containing Grafts.
    Transplantation. 2018;102:1300-1306.
    PubMed     Text format     Abstract available

  56. LIKHITSUP A, Helzberg JH, Alba LM, Larkin MK, et al
    Persistent Alpha-galactosidase A Deficiency following Simultaneous Liver-Kidney Transplantation in a Patient with Fabry Disease.
    Transplantation. 2018 Apr 24. doi: 10.1097/TP.0000000000002257.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: